Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 256 participants.

Also called NCT01186107

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 256 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01186107
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01186107. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
Acronym
ESSENCE-DM2
Condition
Diabetes
Intervention (Device)
Endeavor Resolute stent
Intervention (Device)
Cypher stent
Lead sponsor
Seung-Jung Park (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct01186107
Content hash
920cbb524e2e478b5d49c80bb299793ce29f77a483749fc2ca77df8843c23b7a